Analyst Coverage
The following are the sell-side analysts that cover Glanbia and publish research on a regular basis.
|
Institution |
Analyst |
Location |
|---|---|---|
|
Barclays |
Alex Sloane |
London |
|
Berenberg |
Matthew Abraham |
London |
|
Davy |
Cathal Kenny |
Dublin |
|
Deutsche Numis |
Damian McNeela |
London |
|
Exane BNP Paribas |
Nicola Tang |
London |
|
Goodbody |
Patrick Higgins |
Dublin |
|
Kepler |
Karel Zoete |
Amsterdam |
|
Mizuho |
John Baumgartner |
New York |
|
Morgan Stanley |
David Roux |
London |
|
Oddo BHF |
Fatma Agnès Hamdani |
Paris |
Analyst Consensus
The consensus forecast is outlined below. This consensus has been compiled by Glanbia and is based on inputs received from 8 analysts. Publication of the consensus does not imply endorsement of these estimates by Glanbia. The consensus was last updated on 05 March 2026.
Any opinions, forecasts, estimates, projections or predictions regarding Glanbia’s performance made by the analysts are exclusively theirs and do not represent the opinions, forecasts, estimates, projections or predictions of Glanbia or its management. Glanbia disclaims any liability for the accuracy or completeness of such information and does not assume any obligation to update it even if it becomes aware of any changes.
| In $ millions unless otherwise stated | FY26 Consensus |
| Revenue | |
| Performance Nutrition | 1,817.8 |
| Health & Nutrition | 675.2 |
| Dairy Nutrition | 1,554.0 |
| Group | 4,047.0 |
| EBITDA | |
| Performance Nutrition | 243.3 |
| Health & Nutrition | 124.9 |
| Dairy Nutrition | 156.2 |
| Group | 524.3 |
| EBITDA Margin | |
| Performance Nutrition | 13.4% |
| Health & Nutrition | 18.5% |
| Dairy Nutrition | 10.1% |
| Group | 13% |
| Net Income | 356.1 |
| Adjusted Earnings per Share ("EPS") | 145.8 $cent |
Note: numbers may not sum up because of rounding. Adjusted EPS consensus is in line with the Company's methodology.
